KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShares IssuedShares OutstandingShares OutstandingShares RepurchasedWages, Salaries and Other
Ratios

Globus Medical (GMED) Shares Repurchased (2011 - 2025)

Globus Medical posted quarterly Shares Repurchased of $45.0 million for Q4 2025, up 4400.0% year-on-year from $1.0 million in Q4 2024, and up 12.5% on a QoQ basis from $40.0 million in Q3 2025.

Globus Medical (GMED) has 4 years of Shares Repurchased data on file, last reported at $45.0 million in Q4 2025.

  • For the quarter ending Q4 2025, Shares Repurchased rose 4400.0% year-over-year to $45.0 million; the trailing twelve-month figure through Mar 2026 stood at $110.0 million (down 42.98% YoY), and the FY2025 full-year result was $300.5 million, up 250.23% from the prior year.
  • Shares Repurchased for Q4 2025 stood at $45.0 million, up from $40.0 million in the prior quarter.
  • Across five years, Shares Repurchased topped out at $190.5 million in Q1 2025 and bottomed at $1.0 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Repurchased (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 180.00 Mn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 105.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 421.80 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 100.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 74.30 Mn
10 Globus Medical 10.79 Bn 10.16 Bn 525.79 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 45.00 Mn
Dec 31, 2025 45.00 Mn
Sep 30, 2025 40.00 Mn
Sep 30, 2025 40.00 Mn
Jun 30, 2025 25.00 Mn
Jun 30, 2025 25.00 Mn
Mar 31, 2025 190.45 Mn
Mar 31, 2025 190.45 Mn
Dec 31, 2024 1.00 Mn
Dec 31, 2024 1.00 Mn
Jun 30, 2024 1.47 Mn
Jun 30, 2024 1.47 Mn
Mar 31, 2024 83.32 Mn
Mar 31, 2024 83.32 Mn
Jun 30, 2020 30.81 Mn
Jun 30, 2020 30.81 Mn
Mar 31, 2020 73.86 Mn
Mar 31, 2020 73.86 Mn
Dec 31, 2011 21,000.00
Dec 31, 2011 21,000.00